Stock VIVE VIVESTO AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Vivesto AB

Equities

VIVE

SE0000722365

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.274 SEK +2.05% Intraday chart for Vivesto AB +1.48% -32.76%
Jul. 01 Vivesto AB Receives Positive Cantrixil Preclinical Efficacy Data CI
May. 23 Vivesto AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vivesto receives positive Cantrixil preclinical efficacy data
AQ
Vivesto AB Receives Positive Cantrixil Preclinical Efficacy Data
CI
Report from Annual General Meeting in Vivesto AB
AQ
Vivesto AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Notice of Annual General Meeting in Vivesto AB
AQ
Transcript : Vivesto AB - Special Call
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26
AQ
Vivesto doses first patient in its clinical Paccal Vet trial
AQ
Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial
CI
Vivesto AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Vivesto's international patent application for XR-18 receives positive decision
AQ
Vivesto's International Patent Application for XR-18 Receives Positive Decision
CI
Vivesto Gains on Receipt of US Approval for Pilot Clinical Trial of Drug Candidate Paccal Vet
MT
Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment
AQ
Vivesto AB's US Clinical Paccal Vet Trial Receives Approval to Start Patient Recruitment
CI
Vivesto’s Paccal Vet granted FDA MUMS designation
AQ
Vivesto makes impairment charge following withdrawal of European market authorizations for Apealea
AQ
Vivesto AB Reports Positive Preclinical Data Supporting Continued Development of Cantrixil
CI
Vivesto reports positive preclinical data supporting continued development of Cantrixil
AQ
Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIVE Stock
  4. News Vivesto AB